Login Register
English
0

Cart

$ 0

FAS-L Polyclonal Antibody

FAS-L Polyclonal Antibody

Views(2) Publications(0) Catalog no(ABP58530)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name FAS-L Polyclonal Antibody
Immunogen Synthesized peptide derived from part region of human FAS-L protein at amino acid sequence of 121-170
Host Rabbit
Reactivity Human,Rat,Mouse,
Applications IHC,IF,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-200;ELISA 1:10000-20000;IF 1:50-200
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative Tumor necrosis factor ligand superfamily member 6; Apoptosis antigen ligand; APTL; CD95 ligand; CD95-L; Fas antigen ligand; Fas ligand; FasL; CD antigen CD178

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background FASLG is a member of the tumor necrosis factor superfamily. The primary function of the encoded transmembrane protein is the induction of apoptosis triggered by binding to FAS. The FAS/FASLG signaling pathway is essential for immune system regulation, including activation-induced cell death (AICD) of T cells and cytotoxic T lymphocyte induced cell death. It has also been implicated in the progression of several cancers. Defects in FASLG may be related to some cases of systemic lupus erythematosus (SLE). Alternatively spliced transcript variants have been described. FASLG (Fas Ligand) is a Protein Coding gene. Diseases associated with FASLG include Autoimmune Lymphoproliferative Syndrome and Faslg-Related Autoimmune Lymphoproliferative Syndrome. Among its related pathways are Allograft rejection and Akt Signaling.
Gene ID 356
Alternative Tumor necrosis factor ligand superfamily member 6; Apoptosis antigen ligand; APTL; CD95 ligand; CD95-L; Fas antigen ligand; Fas ligand; FasL; CD antigen CD178
Others The antibody detects endogenous levels of FAS-L
Accession P48023

Image & description

Fig.1. Immunohistochemical analysis of paraffin-embedded Human-colon-cancer, antibody was diluted at 1:100.

Fig.1. Immunohistochemical analysis of paraffin-embedded Human-colon-cancer, antibody was diluted at 1:100.

Fig.2. Immunohistochemical analysis of paraffin-embedded Human-colon-cancer, antibody was diluted at 1:100.

Fig.2. Immunohistochemical analysis of paraffin-embedded Human-colon-cancer, antibody was diluted at 1:100.

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “FAS-L Polyclonal Antibody”